Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Roku Inc. Class A Common Stock (ROKU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Roku Inc. Class A Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Roku Inc. Class A Common Stock trades at $152.85 (market cap $22.84B). The key difference: Roku Inc. Class A Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is more actively traded (2,179,278 versus 1,030,322). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Roku Inc. Class A Common Stock for 1 Days on average.
| HALO | ROKU | |
|---|---|---|
Market Cap | $12.58B | $22.84B |
Volume | 2,179,278 | 1,030,322 |
Sector | Health | Media |
52-Week High | $115.22 | $159.76 |
52-Week Low | $61.63 | $82.93 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $20.76B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Roku Inc. Class A Common Stock
Roku operates a streaming platform that combines its operating system, streaming devices, TV partnerships, and advertising services. It connects viewers with streaming content and services.
Read more on ROKU →
